Status:
COMPLETED
Detection of Colonic Polyps Via a Large Scale Artificial Intelligence (AI) System
Lead Sponsor:
Shaare Zedek Medical Center
Collaborating Sponsors:
Google LLC.
Conditions:
Colonic Polyp
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Colonoscopy is the gold standard for detection and removal of precancerous lesions, and has been amply shown to reduce mortality. However, the miss rate for polyps during colonoscopies is 22-28%, whil...
Eligibility Criteria
Inclusion
- Healthy subjects undergoing routine screening or surveillance colonoscopy in an ambulatory non urgent setting.
- Able to understand the study protocol and sign inform consent.
Exclusion
- Previous surgery involving the colon or rectum
- Known diagnosis of colorectal cancer
- Known history of inflammatory bowel disease
- Known or suspected diagnosis of familial polyposis syndrome
Key Trial Info
Start Date :
May 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04693078
Start Date
May 18 2020
End Date
December 30 2020
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Digestive Diseases Institute, Shaare Zedek Medical Center
Jerusalem, Israel, 90301